TNIK

Across TCGA pan-cancer cohorts, TNIK Mutation is linked to patient survival in 7 of 34 cancer types, making it a survival-associated TNIK data layer compared with 23 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher TNIK Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated TNIK expression acts as an unfavorable survival marker, although some lineages such as UCEC and SKCM show a favorable association.

UCEC, CHOL, and THCA are the cancer types where TNIK Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	0.906	0.610	.001	36	view →
CHOL	OS	Median	All	0.019	0.800	<.001	24	view →
THCA	DFS	Median	All	0.095	0.896	<.001	18	view →
PRAD	OS	Median	All	0.491	0.893	<.001	8	view →
SARC	DFS	Median	All	0.179	0.594	.031	6	view →
READ	OS	Median	III,IV	0.328	0.751	.003	3	view →
SKCM	DFS	Median	II,III,IV	0.724	0.539	.041	1	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

TNIK–UCEC (DFS)

Open the UCEC breakdown →